InsidersTradesSigma
Browse the full record of transactions filed by Kay e Gerald, 董事长兼首席执行官. Officer active across 1 company, notably Integrated Biopharma INC. Aggregated, 2 reports have been published. Activity tracked since 6 May 2022. The latest transaction was filed on 6 May 2022 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Gerald E. Kay is the Executive Chairman and President of Integrated Biopharma Inc. He leads the company's operations and strategy, providing a clear vision for its development. Kay has extensive experience in the biopharmaceutical sector, enabling him to guide the company towards innovation and sustainable growth.